Search results
Psoriatic Arthritis Drugs Comparably Improve Joint Outcomes
Medscape· 5 days agoReal-world study data suggest there is little difference among five drug classes commonly used to...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 4 days agoThe studies also achieved a key secondary endpoint of endoscopic improvement. Skyrizi is already...
Psoriasis study shows high level of arthritis symptoms in patients
Medical Xpress· 5 days agoThe 25% figure confirms existing knowledge that up to a third will go on to develop psoriatic ...
Phase 3 Trial Supports Ixekizumab in Juvenile PsA, ERA
Medscape· 4 days agoIxekizumab (Taltz), an interleukin-17A inhibitor that's already approved for the treatment of ...
Study led by UChicago Medicine physician finds new | Newswise
Newswise· 7 days agoA medication used for psoriasis and psoriatic arthritis is proving to be an effective treatment for moderate to severe ulcerative colitis ...
Izokibep Enthesitis Benefit Lacking in Phase 2b/3 PsA Trial
Medscape· 5 days agoThe primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce...
FDA Approves Skyrizi for Ulcerative Colitis
Medscape· 5 days agoThe approval is the fourth indication for the anti–interleukin 23 monoclonal antibody after approval for Crohn's disease, psoriatic arthritis, and plaque...
Certain Clinical Factors Tied to Poor Response to Biologics for Psoriasis
MedPage Today· 6 days agoPrevious exposure to biologics, higher BMI, smoking all negatively linked to response
Psoriasis: Features That May Affect Biologic Rx Outcomes
Medscape· 6 days agoSeveral clinical characteristics were negatively associated with responses to biologics in a...
Gerber LLC Makes New $342,000 Investment in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 7 days agoGerber LLC bought a new stake in Amgen Inc. (NASDAQ:AMGN – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission ...